| Application no. and date | 17773281.5 (espacenet) (Federated) (European Patent Register), 20170331 | | Patent/reg. no. and date | DK/EP 3438096, 20201202 | | Publication date | 20190206 | | Priority no. and date | CN 201610202881, 20160401 | | EP pub. no. and date |
EP 3438096 20190206 | | Effective date | | | Applicant/owner | Impact Therapeutics, Inc, Room 603, No.3 Building
111 Xiangke Road
China (Shanghai) Pilot Free Trade Zone
Shanghai 201210, CN | | Applicant ref. no. | BT/GP/163435 | | Inventor | CAI, Suixiong, Room 901 No. 14 Building
573 Bibo Road
Shanghai 201203, CN,
HUANG, Ping, Room 301
No. 7 Building
90 Delin Road
Pudong New District
Shanghai 200131, CN | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | C07D 239/96 (2006.01) | | Title | Fremgangsmåde til fremstilling af 1-(arylmethyl)quinazolin-2,4-(1H, 3H)-dioner | | Int. application no. | CN2017078913 | | Int. publication no. | WO2017167251 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
